ESC 365 - Audience Q&A

Open Access

Audience Q&A

Session: Sustained LDL-C reduction: from long-term trials to real-world implementation

Topic: Lipid-Lowering Agents

Speaker: Professor K. Ray (London, GB)

Sponsored by Novartis Pharma AG

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

91 presentations

13 followers

8 more presentations in this session

Welcome and introduction

Speaker: Professor K. Ray (London, GB)

Bridging guidelines to practice: why patients remain outside of LDL-C goals

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)

Value of sustained LDL-C lowering: learnings from long-term data

Speaker: Professor K. Ray (London, GB)

Real-world and implementation science: insights about siRNA

Speaker: Doctor C. Ballantyne (Houston, US)

Shared treatment decision making: a multidisciplinary and patient partnership approach (patient testimonial video)

Access the full session

Sustained LDL-C reduction: from long-term trials to real-world implementation

Speakers: Professor K. Ray, Professor K. Ray, Assistant Professor S. Kohsaka, Professor K. Ray, Doctor C. Ballantyne

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources